Spectrophotometric determination of alendronate in pharmaceutical formulations via complex formation with Fe(III) ions

被引:143
作者
Kuljanin, J
Jankovic, I
Nedeljkovic, J
Prstojevic, D
Marinkovic, V
机构
[1] Vinca INst Nucl Sci, Lab Radiat Chem & Phys, YU-11001 Belgrade, Yugoslavia
[2] ZDRAVLJE Pharmaceut & Chem Ind, Qual Control Sector, YU-16000 Leskovac, Yugoslavia
关键词
complex formation; alendronate; iron(III) chloride; spectrophotometry;
D O I
10.1016/S0731-7085(02)00021-3
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
The formation of the complex between alendronate, non-chromophoric bisphosphonate drug important for the treatment of a variety of bone diseases, and iron(III) chloride in perchloric acid solution was studied. The stoichiometric ratio of alendronate to Fe(III) ions in the chromophoric complex was determined to be 1:1. The conditional stability constant was log K'(ave) = 4.50 (SD = 0.15), indicating that the Fe(III)-alendronate complex is a complex of medium stability. The optimum conditions for this reaction were ascertained and a spectrophotometric method was developed for the determination of alendronate in the concentration range 8.1-162.5 mug ml(-1), the detection limit being 2 mug ml(-1). The method was validated for the direct determination of alendronate in tablet dosage formulations. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:1215 / 1220
页数:6
相关论文
共 18 条
[1]   KRITISCHE UNTERSUCHUNGEN UBER DIE GRENZEN DER ANWENDBARKEIT DER METHODE DER KONTINUIERLICHEN VARIATIONEN NACH JOB .1. TEIL [J].
ASMUS, E .
FRESENIUS ZEITSCHRIFT FUR ANALYTISCHE CHEMIE, 1961, 183 (05) :321-333
[2]  
COTTON FA, 1966, ADV INORG CHEM, P847
[3]  
*COUNC EUR, 1997, EUR PHARM, P128
[4]   Complex ions. II. The stability and activity coefficients of the silver-ammonia ion [J].
Derr, PF ;
Stockdale, RM ;
Vosburgh, WC .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1941, 63 :2670-2674
[5]  
Ettinger B, 1998, AM J MANAG CARE, V4, P1377
[6]  
Karpf DB, 1997, JAMA-J AM MED ASSOC, V277, P1159
[7]  
Kirk JK, 1996, AM FAM PHYSICIAN, V54, P2053
[8]   IMPROVED DETERMINATION OF THE BISPHOSPHONATE ALENDRONATE IN HUMAN PLASMA AND URINE BY AUTOMATED PRECOLUMN DERIVATIZATION AND HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH FLUORESCENCE AND ELECTROCHEMICAL DETECTION [J].
KLINE, WF ;
MATUSZEWSKI, BK .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1992, 583 (02) :183-193
[9]   Bisphosphonate therapy [J].
Licata, AA .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1997, 313 (01) :17-22
[10]   FORMATION OF A CHROMOPHORIC COMPLEX BETWEEN ALENDRONATE AND COPPER(II) IONS [J].
OSTOVIC, D ;
STELMACH, C ;
HULSHIZER, B .
PHARMACEUTICAL RESEARCH, 1993, 10 (03) :470-472